Idorsia is reaching out for more – we have more passion for science, we see more opportunities, and we want to help more patients.
The purpose of Idorsia is to challenge accepted medical paradigms, answering the questions that matter most.
To achieve this, we will discover, develop, and commercialize transformative medicines – either with in-house capabilities or together with partners – and evolve Idorsia into a leading biopharmaceutical company, with a strong scientific core.
Headquartered near Basel, Switzerland – a European biotech hub – Idorsia has a highly experienced team of dedicated professionals, covering all disciplines from bench to bedside; QUVIVIQ™ (daridorexant), a different kind of insomnia treatment with the potential to revolutionize this mounting public health concern; strong partners to maximize the value of our portfolio; a promising in-house development pipeline; and a specialized drug discovery engine focused on small-molecule drugs that can change the treatment paradigm for many patients.
Find out more about each of our key strengths
Our strategic priorities
+ Unlocking the value of QUVIVIQ
+ Nurturing our strong alliances
+ Leveraging our innovative pipeline
+ Targeting our drug discovery
+ Making the money last
Our people
Our success depends on our people. Our talented and diverse team is passionate about science, and we are committed to working collaboratively to bring new medicines to patients.
Our leaders
Idorsia has a strong and visionary leadership team with the power and drive to create more remarkable innovations and more new medicines.
provides oversight and good governance standards for our company.
is responsible for the company strategy and financial stability.
is responsible for execution of the company strategy and operational decision-making.
Partnerships
Idorsia considers sophisticated partnerships to strategically access technologies or products, and to maximize the value of our discovery engine and clinical pipeline.
